Research map: Microglial immunometabolic reprogramming in Alzheimer's disease: From mitochondrial dysfunction and redox imbalance to NLRP3 inflammasome-driven neuroinflammation
Back to the article
Papers in this map
Neurotoxic reactive astrocytes are induced by activated microglia
· Shane A. Liddelow · 2017 · 8394 citations · Cited by this paper
Does HIV-1 infection drive Alzheimer’s disease pathobiology?
· Elizabeth Etafo · 2026 · Cites this paper
From mild cognitive impairment to moderate Alzheimer's disease: Associations between decision-making capacity and awareness
· 2026 · Related
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
· Karen V. Swanson · 2019 · 4883 citations · Cited by this paper
Projected lecanemab wastage from vial discard: Simulation based on Japanese interim post-marketing surveillance summary statistics
· 2026 · Related
Complement and microglia mediate early synapse loss in Alzheimer mouse models
· Soyon Hong · 2016 · 3522 citations · Cited by this paper
Mild behavioral impairment-apathy and Alzheimer's disease plasma phosphorylated tau biomarker levels
· 2026 · Related
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
· Fangda Leng · 2020 · 3295 citations · Cited by this paper
Elevated ferritin expression in microglia and extracellular amyloid-β deposition are associated with reduced neurofibrillary degeneration in human isocortex, but not allocortex
· 2026 · Related
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
· Susanne Krasemann · 2017 · 3194 citations · Cited by this paper
Associations between higher-order executive planning and subjective cognitive decline in middle-aged individuals
· 2026 · Related
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
· Michael Thomas Heneka · 2012 · 2962 citations · Cited by this paper
Recruitment challenges and strategies for engaging the Peruvian population in the ReDLat Study
· 2026 · Related
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
· Clifford R. Jack · 2024 · 2682 citations · Cited by this paper
Disease burden of Alzheimer's disease and other dementias in older adults
· 2026 · Related
Gut microbiome alterations in Alzheimer’s disease
· Nicholas M. Vogt · 2017 · 2174 citations · Cited by this paper
Performance of the participant self-rating version of the Quick Dementia Rating System in a racially diverse cohort of non-demented older adults
· 2026 · Related
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
· Axel Montagne · 2015 · 2171 citations · Cited by this paper
Precuneus amyloid-β deposition involving the association of irritability and cognitive decline: A multi-cohort longitudinal study
· 2026 · Related
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
· Evanna L. Mills · 2018 · 1944 citations · Cited by this paper
Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment
· 2025 · Related
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
· Evandro Fei Fang · 2019 · 1774 citations · Cited by this paper
NLRP3 inflammasome activation drives tau pathology
· Christina Ising · 2019 · 1587 citations · Cited by this paper
The glymphatic pathway in neurological disorders
· Martin Kaag Rasmussen · 2018 · 1577 citations · Cited by this paper
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
· Tyler Kent Ulland · 2017 · 1326 citations · Cited by this paper
New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
· Zhenyu Zhong · 2018 · 1214 citations · Cited by this paper
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
· Carmen Venegas · 2017 · 1018 citations · Cited by this paper
A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease
· Sung Hoon Baik · 2019 · 890 citations · Cited by this paper
Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling
· Hongxu Xian · 2022 · 844 citations · Cited by this paper
TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge
· Alicia A. Nugent · 2020 · 787 citations · Cited by this paper
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
· Raymond Scott Turner · 2015 · 737 citations · Cited by this paper
Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains
· Douglas M. Zeppenfeld · 2016 · 664 citations · Cited by this paper
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
· Afzal Ali Misrani · 2021 · 657 citations · Cited by this paper
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease
· Hong Lian · 2016 · 630 citations · Cited by this paper
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
· Alexander Hooftman · 2020 · 623 citations · Cited by this paper
Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
· Colin Dempsey · 2016 · 589 citations · Cited by this paper
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
· Marina Saresella · 2016 · 498 citations · Cited by this paper
NAD + supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency
· Yujun Hou · 2018 · 486 citations · Cited by this paper
Human microglial state dynamics in Alzheimer’s disease progression
· Na Sun · 2023 · 464 citations · Cited by this paper
Source: OpenAlex (CC0)